Initial Results from Summit: An Ongoing, 3-Part, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of Bezuclastinib in Adult Patients with NonAdvancedSystemic Mastocytosis(NonAdvSM)
American Academy of Asthma, Allergy & Immunology Annual Meeting